NCT00525733 - Standard Antiretroviral v. Multi-class Therapy in Acutely HIV-1 Infected Antiretroviral-Naïve Subjects (ADARC 2007-01) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions

HIV Infections

Interventions

DRUG

darunavir 800 mg

darunavir 800mg tablet will be administered with 100 mg capsule of ritonavir once daily (may be taken with or without food)

DRUG

FTC 200 mg/TDF 300mg

Emtricitabine/tenofovir DF fixed-dose tablet containing 200 mg of emtricitabine and 300 mg of tenofovir DF will be administered orally as one tablet once daily (may be taken with or without food)

DRUG

Maraviroc

Maraviroc will be administered twice daily in 150 mg tablets (may be taken with or without food)

DRUG

Raltegravir

Raltegravir will be administered twice daily as 1-400 mg tablets (to be taken with food)

DRUG

Ritonavir 100 mg

one tablet of ritonavir is taken with darunavir daily

Trial Locations (2)

10021

Rockefeller University, New York

10065

The Rockefeller University, New York